Welcome to the e-CCO Library!

P292: Development of a predictive model for the diagnosis of Crohn’s disease when ileocolonoscopy is insufficient: a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Boal Carvalho*1, M. Marques2, B. Rosa1, H. Cardoso2, F. Machado3, G. Macedo2, J. Cotter1, 4, 5

Created: Friday, 22 February 2019, 9:49 AM
P292: Effect of drug therapy on the lipid profiles of patient with Inflammatory Bowel Disease: a systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: Sleutjes, J.A.M.(1);Roeters van Lennep , J.E.(2);Boersma , E.(3);de Vries , A.C.(1);van der Woude , C.J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P292: Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Knezevic Ivanovski1*, S. Knezevic Usaj2, P. Svorcan1, M. Nedeljkovic Protic1

Created: Thursday, 21 February 2019, 9:14 AM
P292: Immunomodulator and biological therapy are increased in inflammatory bowel disease patients with associated immune-mediated inflammatory diseases
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. J. Garcia Garcia*1, M. Pascual Mato1, C. Del Pozo Calzada1, L. Rasines Perez1, B. Castro Senosiain1, J. Crespo Garcia1, M. Rivero Tirado1

Created: Friday, 22 February 2019, 9:41 AM
P292: Perianal disease: far beyond a simple feature of Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Xavier S.*1, Gonçalves T.1, Castro F.1, Magalhães J.1, Moreira M.1, Cotter J.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P293 Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Busacca, B. Scrivo, E. Giuffrida, L. Guida, L. Carrozza, V. Calvaruso, M. Cappello

Created: Thursday, 30 January 2020, 10:12 AM
P293: Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn's disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Attauabi, M.(1,2)*;Madsen, G.R.(2,3);Bendtsen, F.(2,3);Bjerrum, J.T.(1);Wilkens, R.(4);Theede, K.(2,3);Ilvemark, J.F.K.F.(2,3);Boysen, T.(2,3);Seidelin, J.B.(1);Burisch, J.(2,3);
Created: Friday, 14 July 2023, 11:05 AM
P293: Delayed timing of post-operative colonoscopy within 1 year does not predict a more severe Rutgeerts score
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Singh*1, J. Pang2, 3, C. Seow1, 2, 4, Y. Leung1, 2, 4, K. Novak1, 2, 4, R. Panaccione1, 2, 4, G. Kaplan1, 2, 3, 4

Created: Friday, 22 February 2019, 9:49 AM
P293: Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healing
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ozaki R.*1, Kobayashi T.1, Saito E.1, Toyonaga T.1, Okabayashi S.1, Umeda S.1, Nakano M.1, Matsuoka K.1, Morinaga S.1, Hisamatsu T.2, Hibi T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P293: Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Gonzalez-Lopez1, C. Llamas2, J.M. Giráldez-Montero1, R. Ferreiro3, I. Baston3, M.J. Lamas1, J.E. Dominguez-Munoz3, M. Barreiro-de Acosta3*

Created: Thursday, 21 February 2019, 9:14 AM
P293: Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe
Year: 2022
Source: ECCO'22
Authors: BurischPhD, J.(1,2);Hart, A.(3);Oortwijn, A.(4);Khalid, J.M.(4);Hennessy, F.(5);Knight, H.(5);Meadows, R.(5);Patel, H.(6);Armuzzi, A.(7);
Created: Friday, 11 February 2022, 3:52 PM
P293: Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study
Year: 2021
Source: ECCO'21 Virtual
Authors: Vieujean, S.(1);Loly, J.P.(1);Boutaffala, L.(1);Pariente, B.(2);Reenaers, C.(1);Briquet, A.(3);Lechanteur, C.(3);Beguin, Y.(4);Louis, E.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P293: Prognosis of small intestinal ulcers (SIUs) on capsule endoscopy when magnetic resonance enterography is normal
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. González Suárez1,2, J. Castro-Poceiro1, A. Fernández-Clotet1, J. Feurstein2, E. Ricart1, K. Falchuk2, I. Ordás1, S. Rodriguez1, D. Pleskow2, J. LLach1, J. Panés1, A. Moss2

Created: Friday, 22 February 2019, 9:41 AM
P294 Clinic features and the prognosis of colonic Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Ozgur1, A.I. Hatemi2, Y. Erzin2, A. Çelik2

Created: Thursday, 30 January 2020, 10:12 AM
P294: AMT-101, a gut selective oral IL-10 fusion: results from a Phase 1b study in patients with active Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Posch, M.(1);Tanase, R.(2);Maisaia, K.(3);Jucov, A.(2);Geier, C.(1);Hotson, D.(4);Hamdy, O.(5);Whitney, J.A.(4);Garovoy, M.(6);Kanwar, B.(6);Schreiber, S.(7);
Created: Wednesday, 2 June 2021, 4:12 PM
P294: Assessment of Fatigue and Associated Factors in Patients with Inflammatory Bowel Disease: A Questionnaire-based Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kang, S.B.(1);Jung, S.H.(2)*;Kim, T.O.(3);
Created: Friday, 14 July 2023, 11:05 AM
P294: Distress in inflammatory bowel disease: development of a new assessment tool
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Dibley*1, W. Czuber-Dochan1, S. Woodward1, P. Bassett2, J. Sturt1, C. Norton1

Created: Friday, 22 February 2019, 9:49 AM
P294: Iron-deficiency without anemia in Crohn's disease: what are the predictive factors of recovery?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cúrdia Gonçalves T.*1, Monteiro S.1, Barbosa M.1, Moreira M.J.1, Cotter J.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P294: Microscopic colitis: a missed opportunity to diagnose during colonoscopy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. A. Raju*1, M. Kurien1, T. S. Chew1, K. Chapple2, D. S. Sanders1

Created: Friday, 22 February 2019, 9:41 AM
P294: On the way to disease control: Fatigue as part of a novel composite endpoint in an analysis of a prospective open label observation trial
Year: 2022
Source: ECCO'22
Authors: Tran, F.(1,2);Nikolaus, S.(1);Schrinner, F.(2);Kümpers, J.(1);Lessing, A.(1);Lintner, J.(1);Lessing, M.(1);Sievers, L.K.(1,2);Rosenstiel, P.(2);Aden, K.(1,2);Franke, A.(2);Schreiber, S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM